Mark D. Erion
Impact in
- Physiology top 1%
- Organic Chemistry top 1%
- Organophosphorus compounds synthesis
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
Papers in
-
- Organophosphorus compounds synthesis 13
-
- Diabetes Treatment and Management 12
- Natural Antidiabetic Agents Studies 9
- Co-authors
- M. Rami Reddy (24 shared papers)Paul D. van Poelje (29 shared papers)Scott J. Hecker (5 shared papers)Steven Ealick (12 shared papers)Qun Dang (20 shared papers)Wayne C. Guida (9 shared papers)Srinivas Rao Kasibhatla (13 shared papers)Scott C. Potter (8 shared papers)
- Journals
- Journal of Medicinal Chemistry (26 papers)Journal of the American Chemical Society (12 papers)Biochemistry (7 papers)Journal of Pharmacology and Experimental Therapeutics (7 papers)Journal of Computational Chemistry (6 papers)
- Partner nations
- United StatesJapanBelgium
In The Last Decade
Mark D. Erion
143 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 125
- Physiology 248
- Organic Chemistry 1.7k
- Computational Theory and Mathematics 753
- Endocrinology, Diabetes and Metabolism 732
- Molecular Biology 2.4k
Countries citing papers authored by Mark D. Erion
This map shows the geographic impact of Mark D. Erion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Erion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Erion more than expected).
Fields of papers citing papers by Mark D. Erion
This network shows the impact of papers produced by Mark D. Erion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Erion. The network helps show where Mark D. Erion may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Erion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 380 | |
| 2 | 2008 | 346 | |
| 3 | 2017 | 289 | |
| 4 | 2007 | 215 | |
| 5 | 2008 | 182 | |
| 6 | 1998 | 173 | |
| 7 | 2001 | 172 | |
| 8 | 2010 | 152 | |
| 9 | 2005 | 146 | |
| 10 | 2004 | 137 | |
| 11 | 1991 | 135 | |
| 12 | Free energy calculations in rational drug design | 2001 | 128 |
| 13 | 2012 | 122 | |
| 14 | 1997 | 114 | |
| 15 | 1993 | 109 | |
| 16 | 1997 | 105 | |
| 17 | 2000 | 101 | |
| 18 | 2005 | 100 | |
| 19 | 1995 | 98 | |
| 20 | 1994 | 88 |
About Mark D. Erion
Mark D. Erion is a scholar working on Organic Chemistry, Endocrinology, Diabetes and Metabolism, Molecular Biology, Computational Theory and Mathematics and Physiology, having authored 144 papers that have together received 6.9k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (32 papers), Computational Drug Discovery Methods (20 papers), Metabolism, Diabetes, and Cancer (13 papers), Organophosphorus compounds synthesis (13 papers), Diabetes Treatment and Management (12 papers), Adenosine and Purinergic Signaling (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and Natural Antidiabetic Agents Studies (9 papers). The work is most often cited by research in Physiology (248 citations), Organic Chemistry (1.7k citations), Computational Theory and Mathematics (753 citations), Endocrinology, Diabetes and Metabolism (732 citations) and Molecular Biology (2.4k citations). Mark D. Erion has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include M. Rami Reddy, Paul D. van Poelje, Scott J. Hecker, Steven Ealick, Qun Dang, Wayne C. Guida, Srinivas Rao Kasibhatla, Scott C. Potter, Bheemarao G. Ugarkar and David L. Linemeyer. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of the American Chemical Society, Biochemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Computational Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.